- Did you mean
- registered
Search results - 7 results
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
S aureus (MRSA). While the NSIH- SEP register was the first national Healthcare-associated infection surveillance to migrate to the Healthdata environment in 2017, its actual tools for data collection and ...
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
prevalence of methicillin-resistant S aureus (MRSA). While the NSIH- SEP register was the first national Healthcare-associated infection surveillance to migrate to the Healthdata environment in 2017, its ...
Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.
August 2021. We integrated data from four national data sources: the Belgian vaccine register (vaccination status), COVID-19 Healthdata (laboratory test results), DEMOBEL (sociodemographic/socioeconomic ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
study was prospectively registered at https://clinicaltrials.gov/ (identifier: NCT04111835, protocol ID 28/2019) on 19th of September 2019. Health Topics: Human papillomavirus (HPV) and cervical cancer ...
Linking health survey data with health insurance data: methodology, challenges, opportunities and recommendations for public health research. An experience from the HISlink project in Belgium
national register number. The overall linkage rate was 92.3% and 94.2% for HIS link 2013 and HIS link 2018, respectively. Linked BHIS- BCHI data were used in validation studies (e.g. self-reported breast ...
Burden of disease attributable to risk factors in European countries: A scoping literature review
misinterpretations thus improving comparability among estimates. REGISTRATION: The study protocol has been registered on PROSPERO, CRD42020177477 (available at: https://www.crd.york.ac.uk/ PROSPERO /). Health Topics: ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
the following six months. The trial is registered on ClinicalTrials.gov (NCT04527614). FINDINGS: All included residents (n = 85) and staff members (n = 88) were SARS-CoV-2 infection naïve at third dose ...